Temperature Control During Dialysis Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-08-31

Study Completion Date

2007-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose is to measure the effect of glucose in the dialysis water on blood pressure, pulse rate, and plasma glucose with and without body temperature control

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Target Temperature Management After Cardiac Arrest

NCT01020916

Out-of-hospital Cardiac Arrest

COMPLETED NA

Measurement of Core Temperatures During Therapeutic Hypothermia

NCT01292148

Cardiac Arrest

COMPLETED

Haemostasis and Therapeutic Hypothermia

NCT02179021

Hypothermia Heart Arrest

COMPLETED

Investigation of the Accuracy of Temporal Artery Thermometers

NCT01817881

Sepsis

COMPLETED

Validation of the Measurement Accuracy of the Tcore Thermometer

NCT04489927

Temperature Change, Body

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To clarify the influence of temperature in dialysis water on blood pressure and vasoactive hormones

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Failure, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

temperature control

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age \> 18 years,
2. both men and women,
3. chronic renal failure and dialysis treatment for at least three months

Exclusion Criteria

1. Heart failure,
2. Lung insufficiency,
3. Chronic liver disease,
4. Diabetes mellitus,
5. Malignant disease,
6. Nephrotic syndrome,
7. Lack of compliance,
8. Unwillingness til participate

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No